CME Outfitters Announces neuroscienceCME Clinical Chart Review Series: "Assessing and Managing the Patient with Bipolar Mania"
Offered as a series of three live webcasts/audioconferences premiering Monday, March 15, 2010, from 12:00 p. m.-12:30 p. m. ET, the continuing education series will discuss implementation of strategies to improve assessment, treatment selection, and long-term outcomes in patients with bipolar mania. Clinicians can earn up to 1.5 CE credits by completing all three parts; participation is available online or by phone.
Rockville, MD (PRWEB) February 26, 2010
CME Outfitters, LLC, an award-winning accredited provider of multidisciplinary continuing education (CE), in co-sponsorship with Indiana University School of Medicine, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME Clinical Chart Review series titled "Assessing and Managing the Patient with Bipolar Mania".
Premiering Monday, March 15, 2010, from 12:00 p. m.-12:30 p. m. ET, the premiere installment of neuroscienceCME Clinical Chart Reviews is a special series on the assessment and management of patients with bipolar disorder. Roger S. McIntyre, MD, FRCPC, Head of the Mood Disorders Psychopharmacology Unit at University Health Network, and Associate Professor of Psychiatry and Pharmacology at the University of Toronto in Toronto, ON, will host three interviews on this topic. In each session, guest faculty will join Dr. McIntyre to provide a brief synopsis of a clinical patient chart.
This educational series consists of three live webcasts/audioconferences with question and answer sessions. Live participation options include a live webcast and simultaneous telephone audioconference. Each session will also be available as an archived webcast and podcast shortly after its premiere. Clinicians can earn up to 1.5 CE credits by completing all three parts.
There is no fee to participate or receive CE credit for this series; however, registration is required. Three forms of registration are accepted:
Online: Visit the activities page at http://www. neuroscienceCME. com/PR445 (http://www. neuroscienceCME. com/PR445) and click the Register icon for each individual live Q&A session.
Phone: Call 877.CME. PROS (877.263.7767).
Fax: Visit the activities page at http://www. neuroscienceCME. com/PR445 (http://www. neuroscienceCME. com/PR445), click the Activity Details icon, print and complete the activity details form, and fax to 240.243.1033.
Moderator:
Roger S. McIntyre, MD, FRCPC
Head, Mood Disorders Psychopharmacology Unit
University Health Network
Associate Professor of Psychiatry and Pharmacology
University of Toronto
Toronto, ON
Faculty (Part 1):
Terence A. Ketter, MD
Professor of Psychiatry and Behavioral Sciences
Chief, Bipolar Disorders Clinic
Stanford University School of Medicine
Stanford, CA
Faculty (Part 2):
Mark A. Frye, MD
Professor of Psychiatry
Director, The Integrated Mood Group
Mayo Clinic
Rochester, MN
Faculty (Part 3):
Charles L. Bowden, MD
Nancy U. Karren Clinical Professor
Department of Psychiatry
University of Texas Health Science Center at San Antonio
San Antonio, TX
Live Q&A Dates:
PART 1: Monday, March 15, 2010, 12:00-12:30 p. m. ET
PART 2: Monday, March 29, 2010, 12:00-12:30 p. m.
PART 3: Monday, April 19, 2010, 12:00-12:30 p. m.
Statement of Need:
Optimal management of bipolar disorder begins with accurate diagnosis. The Depression and Bipolar Alliance reported that the misdiagnosis rate is 67% for bipolar patients with the most common misdiagnoses being unipolar depression (60%), anxiety disorder (26%), schizophrenia (18%), and borderline or antisocial personality disorder (17%). When diagnosis is inaccurate or delayed, initial therapy is not properly derived or promptly delivered. In this series of neuroscienceCME Chart Reviews, the faculty will take participants through a series of patient cases focusing on assessment, treatment, and treatment adherence to improve the long-term management of patients with bipolar disorder. Faculty will engage participants in the discussion and development of best practice tips to apply in practice.
Learning Objectives:
At the end of this CE series, participants should be able to:
PART 1: Utilize validated tools to assess for mania symptoms in patients diagnosed with depression.
PART 2: Use best available evidence to guide selection of pharmacotherapy for manic episodes.
PART 3: Build therapeutic alliances with patients with bipolar disorder in order to optimize adherence.
The following learning objectives pertain only to those requesting CNE credit:
PART 1: Describe validated tools used to assess the symptoms of mania and hypomania.
PART 2: Compare pharmacologic agents used to treat mania based on efficacy and safety data.
PART 3: Identify factors that contribute to treatment nonadherence among patients with bipolar mania.
Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in mental health.
Financial Support:
Indiana University School of Medicine and CME Outfitters, LLC, gratefully acknowledge educational grants from Bristol - Myers Squibb Company and Otsuka America Pharmaceutical, Inc., and from Pfizer Inc. in support of this CE series.
Credit Information:
This series offers CE credit for:
Physicians (ACCME/AMA PRA Category 1) Nurses (CNE) - Pending Pharmacists (ACPE)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Post-tests, credit request forms, and activity evaluations can be completed online at www. neuroscienceCME. com (click on the Testing/Certification link under the Activities tab - requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required).
About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www. cmeoutfitters. com (http://www. cmeoutfitters. com), http://www. neuroscienceCME. com (http://www. neuroscienceCME. com), or call 877.CME. PROS (877.263.7767).
About neuroscienceCME:
NeuroscienceCME. com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME. com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compass™‚ a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www. neuroscienceCME. com (http://www. neuroscienceCME. com) and click on "Subscribe to Clinical Compass™".
Contact: Jessica Primanzon
CME Outfitters, LLC
614.328.4508 direct
240.243.1033 fax
# # #